Project Medtech artwork

Episode 117 | Alison Burklund, Co-Founder & CTO at Nanopath and Kate Rumrill, President and CEO at Ablative Solutions | Two Medtech Entrepreneurs: Early Stage vs. Growth Stage

Project Medtech

English - November 14, 2022 06:00 - 45 minutes - 41.7 MB
Life Sciences Science Homepage Download Google Podcasts Overcast Castro Pocket Casts RSS feed

Previous Episode: Episode 116 | Erika Cheung, Co-Founder at Ethics in Entrepreneurship | A Theranos Whistleblower: The Importance of Ethics in a Startup Company

Next Episode: Episode 118 | Kelly Stanton, Director of Quaity at Qualio | The Importance of Instilling Quality in a Medtech Company's Culture: What Does that Actually Mean?

In this episode, Alison Burklund, Kate Rumrill and Duane Mancini discuss their Medtech companies, comparing and contrasting raising money at a series D vs. series A, culture at a series A vs series D, coming into the CEO role vs. being a co-founder, and so much more.
Alison Burklund LinkedIn
Nanopath Website
Kate Rumrill LinkedIn
Ablative Solutions Website
Project Medtech Website
Duane Mancini LinkedIn
Project Medtech LinkedIn